VYNE

VYNE THERAPEUTICS INC

VYNE·92941V308·US·Common Stock·Healthcare - Biotechnology-13D/G

VYNE (VYNE THERAPEUTICS INC) is held by 21 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($307,380), TWO SIGMA INVESTMENTS, LP ($254,781), GEODE CAPITAL MANAGEMENT, LLC ($192,824). Net institutional sentiment: Bullish.

21
Holders
Avg rating(4 Elite)
$1.4M
Total Value
69% (24)
Fund Consensus
11 buying - 5 selling
VYNESmart Money Verdict
View all
Held by 21 funds
4 elite
Who's Trading
ActivistZXZhang XiaofanJul 14, 2026
ActivistZXZhang Xiaofan5.6%Jun 15, 2026
ActivistNANantahala Capital Management, LLC6.0%May 15, 2026
ActivistCitadel Advisors LLCCitadel Advisors LLC0.0%Nov 14, 2025
ActivistEAEventide Asset Management, LLC0.0%Nov 14, 2025
ActivistCACormorant Asset Management, LP0.0%Nov 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
514,443(+1585.3%)$307,3800.0%+8.81%
26
Increased
426,412(+93.8%)$254,7810.0%+40.38%
37
Increased
322,711(+43.3%)$192,8240.0%-93.64%
21
New
264,557$158,2050.0%+8.47%
34
New
183,443$109,6990.0%+8.47%
33
Increased
179,784(+186.5%)$107,5110.0%+11.81%
24
Increased
158,396(+100.4%)$94,6420.0%+11.30%
35
Increased
95,645(+32.2%)$57,1480.0%-41.44%
18
Decreased
57,784(-42.4%)$34,5260.0%-74.92%
0
Unchanged
44,405$26,5320.0%-79.94%
0
Unchanged
23,110$13,8080.0%-72.45%
0
Unchanged
18,298$10,9300.0%-65.22%
0
New
17,300$10,3370.0%+8.47%
26
Unchanged
15,765$9,4200.0%-71.38%
0
New
1,004$6000.0%+8.47%
17
Unchanged
800$4780.0%+14.29%
0
Unchanged
146$860.0%-64.01%
0
Unchanged
65$390.0%-81.01%
0
Unchanged
43$260.0%-68.45%
0
New
27,569$160.0%+8.47%
17

Showing 1-20 of 24

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used